# BLINCYTO
> **BLA125557** · Biologics License Application · Sponsor: AMGEN · Approved 2014-12-03
## Drug
- **FDA Application Number:** BLA125557
- **Application type:** Biologics License Application
- **Brand name:** BLINCYTO
- **Generic name:** BLINATUMOMAB
- **Active ingredients:** BLINATUMOMAB
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** AMGEN
- **Manufacturer:** Amgen, Inc
- **First approval:** 2014-12-03
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125557)
---
*AI Analytics · CC0 1.0*